{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:27:07Z","timestamp":1789039627025,"version":"build-2803163510"},"reference-count":121,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s13555-026-01733-x","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:30:14Z","timestamp":1779204614000},"page":"3577-3621","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The Role of Inflammatory Biomarkers in Disease Severity and Treatment Response across Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa\u2014A Narrative Review"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3493-2047","authenticated-orcid":false,"given":"Julia Alicja","family":"Lewandowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8372-0438","authenticated-orcid":false,"given":"Agnieszka","family":"Owczarczyk\u2013Saczonek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"1733_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1384055","volume":"11","author":"K Wolk","year":"2024","unstructured":"Wolk K, Schielein M, Maul JT, et al. Patient-reported assessment of medical care for chronic inflammatory skin diseases: an enterprise-based survey. Front Med. 2024;11:1384055. https:\/\/doi.org\/10.3389\/fmed.2024.1384055.","journal-title":"Front Med"},{"key":"1733_CR2","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v105.42945","volume":"105","author":"C Skayem","year":"2025","unstructured":"Skayem C, Taieb C, Halioua B, Baissac C, Saint Aroman M. Epidemiology of psoriasis: a worldwide global study. Acta Derm Venereol. 2025;105:adv42945. https:\/\/doi.org\/10.2340\/actadv.v105.42945.","journal-title":"Acta Derm Venereol"},{"issue":"19","key":"1733_CR3","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020;323(19):1945\u201360. https:\/\/doi.org\/10.1001\/jama.2020.4006.","journal-title":"JAMA"},{"issue":"1","key":"1733_CR4","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2337264","volume":"35","author":"Y Gao","year":"2024","unstructured":"Gao Y, Li C, Tong M, Hu Y, Li Y. Characterization of psoriasis patients in special body areas: real-world evidence from the Chinese Psoriasis Standardized Diagnosis and Treatment Center. J Dermatolog Treat. 2024;35(1):2337264. https:\/\/doi.org\/10.1080\/09546634.2024.2337264.","journal-title":"J Dermatolog Treat"},{"key":"1733_CR5","volume-title":"StatPearls","author":"V Tiwari","year":"2024","unstructured":"Tiwari V, Brent LH. Psoriatic arthritis. In: StatPearls. Treasure Island: StatPearls Publishing; 2024."},{"key":"1733_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1361005","volume":"15","author":"M Afshari","year":"2024","unstructured":"Afshari M, Kolackova M, Rosecka M, \u010celakovsk\u00e1 J, Krejsek J. Unraveling the skin; a comprehensive review of atopic dermatitis, current understanding, and approaches. Front Immunol. 2024;15:1361005. https:\/\/doi.org\/10.3389\/fimmu.2024.1361005.","journal-title":"Front Immunol"},{"issue":"1","key":"1733_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1093\/bjd\/ljad339","volume":"190","author":"J Tian","year":"2023","unstructured":"Tian J, Zhang D, Yang Y, et al. Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study. Br J Dermatol. 2023;190(1):55\u201361. https:\/\/doi.org\/10.1093\/bjd\/ljad339.","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"1733_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000542389","volume":"241","author":"CE Medianfar","year":"2025","unstructured":"Medianfar CE, Fernandez LI, Bouazzi D, Jemec GBE. Global hidradenitis suppurativa epidemiology: exploring themes and gaps beyond Europe, Australia, and the USA. Dermatology. 2025;241(Suppl 1):159\u201370. https:\/\/doi.org\/10.1159\/000542389.","journal-title":"Dermatology"},{"key":"1733_CR9","unstructured":"Ballard K, Sathe NC, Shuman VL. Hidradenitis suppurativa. In: StatPearls. Treasure Island: StatPearls Publishing; 2025. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK534867\/"},{"key":"1733_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41540-025-00498-x","volume":"11","author":"B Mishra","year":"2025","unstructured":"Mishra B, Gou Y, Tan Z, et al. Integrative systems biology framework discovers common gene regulatory signatures in mechanistically distinct inflammatory skin diseases. NPJ Syst Biol Appl. 2025;11:21. https:\/\/doi.org\/10.1038\/s41540-025-00498-x.","journal-title":"NPJ Syst Biol Appl"},{"issue":"2","key":"1733_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s12016-024-08991-7","volume":"66","author":"I Sieminska","year":"2024","unstructured":"Sieminska I, Pieniawska M, Grzywa TM. The immunology of psoriasis-current concepts in pathogenesis. Clin Rev Allergy Immunol. 2024;66(2):164\u201391. https:\/\/doi.org\/10.1007\/s12016-024-08991-7.","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"1733_CR12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.abd.2024.06.001","volume":"99","author":"PR Criado","year":"2024","unstructured":"Criado PR, Miot HA, Bueno-Filho R, Ianhez M, Criado RFJ, de Castro CCS. Update on the pathogenesis of atopic dermatitis. An Bras Dermatol. 2024;99(6):895\u2013915. https:\/\/doi.org\/10.1016\/j.abd.2024.06.001.","journal-title":"An Bras Dermatol"},{"issue":"Suppl 1","key":"1733_CR13","doi-asserted-by":"publisher","first-page":"i3","DOI":"10.1093\/bjd\/ljae238","volume":"192","author":"JW Frew","year":"2025","unstructured":"Frew JW. Unravelling the complex pathogenesis of hidradenitis suppurativa. Br J Dermatol. 2025;192(Suppl 1):i3\u201314. https:\/\/doi.org\/10.1093\/bjd\/ljae238.","journal-title":"Br J Dermatol"},{"issue":"9","key":"1733_CR14","doi-asserted-by":"publisher","first-page":"10259","DOI":"10.3390\/cimb46090611","volume":"46","author":"A S\u00f3jka","year":"2024","unstructured":"S\u00f3jka A, Krajewski PK. Current landscape of chronic inflammatory dermatoses: where we are and where we are heading. Curr Issues Mol Biol. 2024;46(9):10259\u201363. https:\/\/doi.org\/10.3390\/cimb46090611.","journal-title":"Curr Issues Mol Biol"},{"issue":"4","key":"1733_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59040801","volume":"59","author":"F Martora","year":"2023","unstructured":"Martora F, Scalvenzi M, Ruggiero A, Potestio L, Battista T, Megna M. Hidradenitis suppurativa and JAK inhibitors: a review of the published literature. Medicina (Kaunas). 2023;59(4):801. https:\/\/doi.org\/10.3390\/medicina59040801.","journal-title":"Medicina (Kaunas)"},{"key":"1733_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1068260","volume":"13","author":"IH Huang","year":"2022","unstructured":"Huang IH, Chung WH, Wu PC, Chen CB. JAK-STAT signaling pathway in the pathogenesis of atopic dermatitis: an updated review. Front Immunol. 2022;13:1068260. https:\/\/doi.org\/10.3389\/fimmu.2022.1068260.","journal-title":"Front Immunol"},{"issue":"6","key":"1733_CR17","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1080\/09546634.2022.2067819","volume":"33","author":"J Hwang","year":"2022","unstructured":"Hwang J, Rick J, Hsiao J, Shi VY. A review of IL-36: an emerging therapeutic target for inflammatory dermatoses. J Dermatolog Treat. 2022;33(6):2711\u201322. https:\/\/doi.org\/10.1080\/09546634.2022.2067819.","journal-title":"J Dermatolog Treat"},{"issue":"4","key":"1733_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202250075","volume":"53","author":"A Mesas-Fern\u00e1ndez","year":"2023","unstructured":"Mesas-Fern\u00e1ndez A, Bodner E, Hilke FJ, Meier K, Ghoreschi K, Solimani F. Interleukin-21 in autoimmune and inflammatory skin diseases. Eur J Immunol. 2023;53(4):e2250075. https:\/\/doi.org\/10.1002\/eji.202250075.","journal-title":"Eur J Immunol"},{"issue":"27","key":"1733_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000000187","volume":"93","author":"AV Marzano","year":"2014","unstructured":"Marzano AV, Ceccherini I, Gattorno M, et al. Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltimore). 2014;93(27):e187. https:\/\/doi.org\/10.1097\/MD.0000000000000187.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1733_CR20","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1080\/000163501750266783","volume":"59","author":"M Akdis","year":"2001","unstructured":"Akdis M, Trautmann A, Klunker S, Blaser K, Akdis CA. Cytokine network and dysregulated apoptosis in atopic dermatitis. Acta Odontol Scand. 2001;59(3):178\u201382. https:\/\/doi.org\/10.1080\/000163501750266783.","journal-title":"Acta Odontol Scand"},{"key":"1733_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5114\/dr.2017.66223","volume":"104","author":"H My\u015bliwiec","year":"2017","unstructured":"My\u015bliwiec H, Baran A, Flisiak I. Selected aspects of apoptosis in psoriasis. Dermatol Rev. 2017;104:57\u201363. https:\/\/doi.org\/10.5114\/dr.2017.66223.","journal-title":"Dermatol Rev"},{"issue":"2","key":"1733_CR22","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.immuni.2009.01.001","volume":"30","author":"A Strasser","year":"2009","unstructured":"Strasser A, Jost PJ, Nagata S. The many roles of FAS receptor signaling in the immune system. Immunity. 2009;30(2):180\u201392. https:\/\/doi.org\/10.1016\/j.immuni.2009.01.001.","journal-title":"Immunity"},{"issue":"1","key":"1733_CR23","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI9199","volume":"106","author":"A Trautmann","year":"2000","unstructured":"Trautmann A, Akdis M, Kleemann D, et al. T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis. J Clin Invest. 2000;106(1):25\u201335. https:\/\/doi.org\/10.1172\/JCI9199.","journal-title":"J Clin Invest"},{"issue":"10","key":"1733_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0205103","volume":"13","author":"L Szymanski","year":"2018","unstructured":"Szymanski L, Cios A, Lewicki S, Szymanski P, Stankiewicz W. Fas\/FasL pathway and cytokines in keratinocytes in atopic dermatitis - manipulation by the electromagnetic field. PLoS ONE. 2018;13(10):e0205103. https:\/\/doi.org\/10.1371\/journal.pone.0205103.","journal-title":"PLoS ONE"},{"issue":"1","key":"1733_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1046\/j.1365-3083.2003.01183.x","volume":"57","author":"MH Sohn","year":"2003","unstructured":"Sohn MH, Kim JW, Kim WK, Jang GC, Kim KE. Staphylococcal enterotoxin B upregulates Fas-mediated apoptosis of peripheral blood mononuclear cells in childhood atopic dermatitis. Scand J Immunol. 2003;57(1):62\u20137. https:\/\/doi.org\/10.1046\/j.1365-3083.2003.01183.x.","journal-title":"Scand J Immunol"},{"issue":"7","key":"1733_CR26","first-page":"3188","volume":"8","author":"Y Wang","year":"2016","unstructured":"Wang Y, Wang LL, Yang HY, Wang FF, Zhang XX, Bai YP. Interleukin-21 is associated with the severity of psoriasis vulgaris through promoting CD4+ T cells to differentiate into Th17 cells. Am J Transl Res. 2016;8(7):3188\u201396.","journal-title":"Am J Transl Res"},{"issue":"3","key":"1733_CR27","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.alit.2016.10.010","volume":"66","author":"H Mizutani","year":"2017","unstructured":"Mizutani H, Tamagawa-Mineoka R, Nakamura N, Masuda K, Katoh N. Serum IL-21 levels are elevated in atopic dermatitis patients with acute skin lesions. Allergol Int. 2017;66(3):440\u20134. https:\/\/doi.org\/10.1016\/j.alit.2016.10.010.","journal-title":"Allergol Int"},{"issue":"5","key":"1733_CR28","doi-asserted-by":"publisher","first-page":"366","DOI":"10.2500\/aap.2011.32.3468","volume":"32","author":"KW Su","year":"2011","unstructured":"Su KW, Chen PC, Wang IJ. Cord blood soluble Fas ligand and pediatric atopic dermatitis. Allergy Asthma Proc. 2011;32(5):366\u201371. https:\/\/doi.org\/10.2500\/aap.2011.32.3468.","journal-title":"Allergy Asthma Proc"},{"issue":"8","key":"1733_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26083868","volume":"26","author":"A Kimak-Pielas","year":"2025","unstructured":"Kimak-Pielas A, Robak E, Zajdel R, \u017bebrowska A. The relationship between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and Systemic Immune-Inflammation Index markers and response to biological therapy in patients with psoriasis. Int J Mol Sci. 2025;26(8):3868. https:\/\/doi.org\/10.3390\/ijms26083868.","journal-title":"Int J Mol Sci"},{"issue":"14","key":"1733_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13143992","volume":"13","author":"S-H Morariu","year":"2024","unstructured":"Morariu S-H, Cotoi OS, Tiuc\u0103 OM, et al. Blood-count-derived inflammatory markers as predictors of response to biologics and small-molecule inhibitors in psoriasis: a multicenter study. J Clin Med. 2024;13(14):3992. https:\/\/doi.org\/10.3390\/jcm13143992.","journal-title":"J Clin Med"},{"key":"1733_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1585451","volume":"16","author":"X Chen","year":"2025","unstructured":"Chen X, Yang X, Zhang M, Zhao Y, Guo S. Neutrophil-lymphocyte and platelet-lymphocyte ratios as systemic inflammatory biomarkers for atopic dermatitis in US adults: a cross-sectional NHANES study revealing subgroup heterogeneity. Front Immunol. 2025;16:1585451. https:\/\/doi.org\/10.3389\/fimmu.2025.1585451.","journal-title":"Front Immunol"},{"key":"1733_CR32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.2147\/JIR.S501883","volume":"18","author":"L Zhang","year":"2025","unstructured":"Zhang L, Pi J, Wang J, et al. The association of inflammatory indexes derived from peripheral blood cell count and clinical signs with response to treatment with dupilumab in pediatric patients with moderate-to-severe atopic dermatitis. J Inflamm Res. 2025;18:271\u201382. https:\/\/doi.org\/10.2147\/JIR.S501883.","journal-title":"J Inflamm Res"},{"issue":"1","key":"1733_CR33","first-page":"157","volume":"27","author":"R Hammad","year":"2020","unstructured":"Hammad R, Hamdino M, El-Nasser AM. Role of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mean platelet volume in Egyptian patients with psoriasis vulgaris. Egypt J Immunol. 2020;27(1):157\u201368.","journal-title":"Egypt J Immunol"},{"issue":"8","key":"1733_CR34","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1111\/ijd.16744","volume":"62","author":"E \u00d6ks\u00fcm Solak","year":"2023","unstructured":"\u00d6ks\u00fcm Solak E, Baran Ketencioglu B, Cinar SL, Kartal D, Borlu M. The role of new inflammatory markers in determining disease activation and severity in patients with hidradenitis suppurativa. Int J Dermatol. 2023;62(8):1076\u201381. https:\/\/doi.org\/10.1111\/ijd.16744.","journal-title":"Int J Dermatol"},{"issue":"6","key":"1733_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20061475","volume":"20","author":"A Rendon","year":"2019","unstructured":"Rendon A, Sch\u00e4kel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475. https:\/\/doi.org\/10.3390\/ijms20061475.","journal-title":"Int J Mol Sci"},{"key":"1733_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15382","volume":"8","author":"LC Tsoi","year":"2017","unstructured":"Tsoi LC, Stuart PE, Tian C, et al. Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nat Commun. 2017;8:15382. https:\/\/doi.org\/10.1038\/ncomms15382.","journal-title":"Nat Commun"},{"issue":"18","key":"1733_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20184347","volume":"20","author":"K Kamiya","year":"2019","unstructured":"Kamiya K, Kishimoto M, Sugai J, Komine M, Ohtsuki M. Risk factors for the development of psoriasis. Int J Mol Sci. 2019;20(18):4347. https:\/\/doi.org\/10.3390\/ijms20184347.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1733_CR38","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2353\/ajpath.2006.041354","volume":"168","author":"A Gilhar","year":"2006","unstructured":"Gilhar A, Yaniv R, Assy B, Serafimovich S, Ullmann Y, Kalish RS. Fas pulls the trigger on psoriasis. Am J Pathol. 2006;168(1):170\u20135. https:\/\/doi.org\/10.2353\/ajpath.2006.041354.","journal-title":"Am J Pathol"},{"issue":"2","key":"1733_CR39","doi-asserted-by":"publisher","first-page":"84","DOI":"10.2500\/aap.2019.40.4202","volume":"40","author":"J Kim","year":"2019","unstructured":"Kim J, Kim BE, Leung DYM. Pathophysiology of atopic dermatitis: clinical implications. Allergy Asthma Proc. 2019;40(2):84\u201392. https:\/\/doi.org\/10.2500\/aap.2019.40.4202.","journal-title":"Allergy Asthma Proc"},{"issue":"12","key":"1733_CR40","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70029","volume":"5","author":"C Yue","year":"2024","unstructured":"Yue C, Zhou H, Wang X, et al. Atopic dermatitis: pathogenesis and therapeutic intervention. MedComm. 2024;5(12):e70029. https:\/\/doi.org\/10.1002\/mco2.70029.","journal-title":"MedComm"},{"issue":"5","key":"1733_CR41","doi-asserted-by":"publisher","first-page":"970","DOI":"10.3390\/jcm4050970","volume":"4","author":"DJ Panther","year":"2015","unstructured":"Panther DJ, Jacob SE. The importance of acidification in atopic eczema: an underexplored avenue for treatment. J Clin Med. 2015;4(5):970\u20138. https:\/\/doi.org\/10.3390\/jcm4050970.","journal-title":"J Clin Med"},{"issue":"3","key":"1733_CR42","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1111\/cea.12495","volume":"45","author":"W Peng","year":"2015","unstructured":"Peng W, Novak N. Pathogenesis of atopic dermatitis. Clin Exp Allergy. 2015;45(3):566\u201374. https:\/\/doi.org\/10.1111\/cea.12495.","journal-title":"Clin Exp Allergy"},{"issue":"8","key":"1733_CR43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00011-017-1049-z","volume":"66","author":"K Bie\u0144","year":"2017","unstructured":"Bie\u0144 K, \u017bmigrodzka M, Or\u0142owski P, et al. Involvement of Fas\/FasL pathway in the murine model of atopic dermatitis. Inflamm Res. 2017;66(8):679\u201390. https:\/\/doi.org\/10.1007\/s00011-017-1049-z.","journal-title":"Inflamm Res"},{"issue":"2","key":"1733_CR44","doi-asserted-by":"publisher","DOI":"10.1097\/JW9.0000000000000158","volume":"10","author":"SM Eble","year":"2024","unstructured":"Eble SM, Wisco OJ, Boccuto L, et al. Genetic factors associated with hidradenitis suppurativa, a literature review. Int J Womens Dermatol. 2024;10(2):e158. https:\/\/doi.org\/10.1097\/JW9.0000000000000158.","journal-title":"Int J Womens Dermatol"},{"key":"1733_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02965","volume":"9","author":"ARJV Vossen","year":"2018","unstructured":"Vossen ARJV, van der Zee HH, Prens EP. Hidradenitis suppurativa: a systematic review integrating inflammatory pathways into a cohesive pathogenic model. Front Immunol. 2018;9:2965. https:\/\/doi.org\/10.3389\/fimmu.2018.02965.","journal-title":"Front Immunol"},{"issue":"9","key":"1733_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24098428","volume":"24","author":"E Molinelli","year":"2023","unstructured":"Molinelli E, Gioacchini H, Sapigni C, et al. New insight into the molecular pathomechanism and immunomodulatory treatments of hidradenitis suppurativa. Int J Mol Sci. 2023;24(9):8428. https:\/\/doi.org\/10.3390\/ijms24098428.","journal-title":"Int J Mol Sci"},{"key":"1733_CR47","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1561102","volume":"15","author":"L Hu","year":"2025","unstructured":"Hu L, Lu J, Fan H, et al. FAS mediates apoptosis, inflammation, and treatment of pathogen infection. Front Cell Infect Microbiol. 2025;15:1561102. https:\/\/doi.org\/10.3389\/fcimb.2025.1561102.","journal-title":"Front Cell Infect Microbiol"},{"issue":"2","key":"1733_CR48","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3934\/medsci.2022009","volume":"9","author":"M Muraki","year":"2022","unstructured":"Muraki M. Soluble Fas ligand, soluble Fas receptor, and decoy receptor 3 as disease biomarkers for clinical applications: a review. AIMS Med Sci. 2022;9(2):98\u2013267. https:\/\/doi.org\/10.3934\/medsci.2022009.","journal-title":"AIMS Med Sci"},{"issue":"3","key":"1733_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0923-1811(01)00162-1","volume":"28","author":"H Takahashi","year":"2002","unstructured":"Takahashi H, Manabe A, Ishida-Yamamoto A, Hashimoto Y, Iizuka H. Aberrant expression of apoptosis-related molecules in psoriatic epidermis. J Dermatol Sci. 2002;28(3):187\u201397. https:\/\/doi.org\/10.1016\/S0923-1811(01)00162-1.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"1733_CR50","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.advms.2014.10.005","volume":"60","author":"H My\u015bliwiec","year":"2015","unstructured":"My\u015bliwiec H, Baran A, My\u015bliwiec P, G\u00f3rska M, Flisiak I. Upregulation of the sFas\/sFasL system in psoriatic patients. Adv Med Sci. 2015;60(1):64\u20138. https:\/\/doi.org\/10.1016\/j.advms.2014.10.005.","journal-title":"Adv Med Sci"},{"issue":"1","key":"1733_CR51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1159\/000068289","volume":"16","author":"T Yamamoto","year":"2003","unstructured":"Yamamoto T, Nishioka K. Alteration of the expression of Bcl-2, Bcl-x, Bax, Fas, and Fas ligand in the involved skin of psoriasis vulgaris following topical anthralin therapy. Skin Pharmacol Appl Skin Physiol. 2003;16(1):50\u20138. https:\/\/doi.org\/10.1159\/000068289.","journal-title":"Skin Pharmacol Appl Skin Physiol"},{"issue":"2","key":"1733_CR52","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1111\/j.1365-2133.2009.09178.x","volume":"161","author":"SW Son","year":"2009","unstructured":"Son SW, Kim EO, Ryu ES, et al. Upregulation of Fas and downregulation of CD94\/NKG2A inhibitory receptors on circulating natural killer cells in patients with new-onset psoriasis. Br J Dermatol. 2009;161(2):281\u20138. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09178.x.","journal-title":"Br J Dermatol"},{"key":"1733_CR53","doi-asserted-by":"publisher","DOI":"10.1088\/1755-1315\/1325\/1\/012029","volume":"1325","author":"ZM Joodi","year":"2024","unstructured":"Joodi ZM, Al-Saadi BQH. The role of FASL gene polymorphism (rs763110), its serum level and IL21 level with incidence of psoriasis in Iraqi patients. IOP Conf Ser Earth Environ Sci. 2024;1325:012029. https:\/\/doi.org\/10.1088\/1755-1315\/1325\/1\/012029.","journal-title":"IOP Conf Ser Earth Environ Sci"},{"key":"1733_CR54","doi-asserted-by":"publisher","DOI":"10.2478\/rrlm-2018-0024","author":"GG Duran","year":"2018","unstructured":"Duran GG, Kasap M, Gunesacar R, Dogramac\u0131 AC, Denli YG. Investigation of the relation between FAS, FASLG polymorphisms and serum Fas, FasL levels in patients with psoriasis. Rev Romana Med Lab. 2018. https:\/\/doi.org\/10.2478\/rrlm-2018-0024.","journal-title":"Rev Romana Med Lab"},{"key":"1733_CR55","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/nm.1995","volume":"15","author":"R Caruso","year":"2009","unstructured":"Caruso R, Botti E, Sarra M, et al. Involvement of interleukin-21 in the epidermal hyperplasia of psoriasis. Nat Med. 2009;15:1013\u20135. https:\/\/doi.org\/10.1038\/nm.1995.","journal-title":"Nat Med"},{"issue":"10","key":"1733_CR56","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.2174\/138920112802273281","volume":"13","author":"E Botti","year":"2012","unstructured":"Botti E, Spallone G, Caruso R, Monteleone G, Chimenti S, Costanzo A. Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target. Curr Pharm Biotechnol. 2012;13(10):1861\u20137. https:\/\/doi.org\/10.2174\/138920112802273281.","journal-title":"Curr Pharm Biotechnol"},{"key":"1733_CR57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01865","volume":"10","author":"Y Shi","year":"2019","unstructured":"Shi Y, Chen Z, Zhao Z, et al. IL-21 induces an imbalance of Th17\/Treg cells in moderate-to-severe plaque psoriasis patients. Front Immunol. 2019;10:1865. https:\/\/doi.org\/10.3389\/fimmu.2019.01865.","journal-title":"Front Immunol"},{"issue":"9","key":"1733_CR58","doi-asserted-by":"publisher","first-page":"5435","DOI":"10.4049\/jimmunol.1003326","volume":"186","author":"M Sarra","year":"2011","unstructured":"Sarra M, Caruso R, Cupi ML, et al. IL-21 promotes skin recruitment of CD4(+) cells and drives IFN-\u03b3-dependent epidermal hyperplasia. J Immunol. 2011;186(9):5435\u201342. https:\/\/doi.org\/10.4049\/jimmunol.1003326.","journal-title":"J Immunol"},{"issue":"1","key":"1733_CR59","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201709RRRR","volume":"38","author":"D Han","year":"2024","unstructured":"Han D, Li F, Zhao Y, et al. IL-21 promoting angiogenesis contributes to the development of psoriasis. FASEB J. 2024;38(1):e23375. https:\/\/doi.org\/10.1096\/fj.202201709RRRR.","journal-title":"FASEB J"},{"issue":"22","key":"1733_CR60","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.4161\/cc.8.22.9964","volume":"8","author":"R Caruso","year":"2009","unstructured":"Caruso R, Costanzo A, Monteleone G. Pathogenic role of interleukin-21 in psoriasis. Cell Cycle. 2009;8(22):3629\u201330. https:\/\/doi.org\/10.4161\/cc.8.22.9964.","journal-title":"Cell Cycle"},{"key":"1733_CR61","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/819149","volume":"2015","author":"PS de Oliveira","year":"2015","unstructured":"de Oliveira PS, Cardoso PR, Lima EV, et al. IL-17A, IL-22, IL-6, and IL-21 serum levels in plaque-type psoriasis in Brazilian patients. Mediators Inflamm. 2015;2015:819149. https:\/\/doi.org\/10.1155\/2015\/819149.","journal-title":"Mediators Inflamm"},{"issue":"6","key":"1733_CR62","doi-asserted-by":"publisher","first-page":"837","DOI":"10.3892\/br.2013.166","volume":"1","author":"F Gong","year":"2013","unstructured":"Gong F, Su Q, Pan YH, Huang X, Shen WH. The emerging role of interleukin-21 in allergic diseases. Biomed Rep. 2013;1(6):837\u20139. https:\/\/doi.org\/10.3892\/br.2013.166.","journal-title":"Biomed Rep"},{"issue":"2","key":"1733_CR63","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.jdermsci.2010.08.016","volume":"60","author":"A Costanzo","year":"2010","unstructured":"Costanzo A, Chimenti MS, Botti E, Caruso R, Sarra M, Monteleone G. IL-21 in the pathogenesis and treatment of skin diseases. J Dermatol Sci. 2010;60(2):61\u20136. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.08.016.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"1733_CR64","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1172\/JCI32310","volume":"119","author":"H Jin","year":"2009","unstructured":"Jin H, Oyoshi MK, Le Y, et al. IL-21R is essential for epicutaneous sensitization and allergic skin inflammation in humans and mice. J Clin Invest. 2009;119(1):47\u201360. https:\/\/doi.org\/10.1172\/JCI32310.","journal-title":"J Clin Invest"},{"key":"1733_CR65","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jdin.2024.03.002","volume":"15","author":"N Holgersen","year":"2024","unstructured":"Holgersen N, Nielsen VW, Rosen\u00f8 NAL, et al. Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa. JAAD Int. 2024;15:170\u20138. https:\/\/doi.org\/10.1016\/j.jdin.2024.03.002.","journal-title":"JAAD Int"},{"issue":"2","key":"1733_CR66","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/ced\/llae324","volume":"50","author":"N Kearney","year":"2025","unstructured":"Kearney N, Chen X, Bi Y, et al. Treatment of hidradenitis suppurativa with adalimumab in the PIONEER I and II randomized controlled trials reduced indices of systemic inflammation, recognized risk factors for cardiovascular disease. Clin Exp Dermatol. 2025;50(2):339\u201347. https:\/\/doi.org\/10.1093\/ced\/llae324.","journal-title":"Clin Exp Dermatol"},{"issue":"9","key":"1733_CR67","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1111\/jdv.18175","volume":"36","author":"T Gambichler","year":"2022","unstructured":"Gambichler T, Hessam S, Cramer P, Abu Rached N, Bechara FG. Complete blood collection-based systemic inflammation biomarkers for patients with hidradenitis suppurativa. J Eur Acad Dermatol Venereol. 2022;36(9):1593\u20136. https:\/\/doi.org\/10.1111\/jdv.18175.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"1733_CR68","doi-asserted-by":"publisher","first-page":"352","DOI":"10.12865\/CHSJ.46.04.05","volume":"46","author":"A Yorulmaz","year":"2020","unstructured":"Yorulmaz A, Hayran Y, Akpinar U, Yalcin B. Systemic immune-inflammation index (SII) predicts increased severity in psoriasis and psoriatic arthritis. Curr Health Sci J. 2020;46(4):352\u20137. https:\/\/doi.org\/10.12865\/CHSJ.46.04.05.","journal-title":"Curr Health Sci J"},{"issue":"1","key":"1733_CR69","doi-asserted-by":"publisher","DOI":"10.5826\/dpc.1401a65","volume":"14","author":"F Tamer","year":"2024","unstructured":"Tamer F, Edek YC, Aksakal AB. Effect of treatment with biologic agents on the novel inflammatory biomarkers systemic immune inflammation index and systemic inflammation response index for psoriasis. Dermatol Pract Concept. 2024;14(1):e2024065. https:\/\/doi.org\/10.5826\/dpc.1401a65.","journal-title":"Dermatol Pract Concept"},{"issue":"4","key":"1733_CR70","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4103\/ijd.IJD_427_17","volume":"63","author":"SB Batmaz","year":"2018","unstructured":"Batmaz SB. Simple markers for systemic inflammation in pediatric atopic dermatitis patients. Indian J Dermatol. 2018;63(4):305\u201310. https:\/\/doi.org\/10.4103\/ijd.IJD_427_17.","journal-title":"Indian J Dermatol"},{"issue":"4","key":"1733_CR71","doi-asserted-by":"publisher","first-page":"e262","DOI":"10.7417\/T.2017.2017","volume":"168","author":"M Dogru","year":"2017","unstructured":"Dogru M, Citli R. The neutrophil-lymphocyte ratio in children with atopic dermatitis: a case-control study. Clin Ter. 2017;168(4):e262\u20135. https:\/\/doi.org\/10.7417\/T.2017.2017.","journal-title":"Clin Ter"},{"issue":"1","key":"1733_CR72","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3390\/life14010114","volume":"14","author":"OM Tiuc\u0103","year":"2024","unstructured":"Tiuc\u0103 OM, Morariu SH, Mariean CR, Tiuc\u0103 RA, Nicolescu AC, Cotoi OS. Impact of blood-count-derived inflammatory markers in psoriatic disease progression. Life (Basel). 2024;14(1):114. https:\/\/doi.org\/10.3390\/life14010114.","journal-title":"Life (Basel)"},{"issue":"12","key":"1733_CR73","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1111\/1346-8138.16558","volume":"49","author":"M S\u00e1nchez-D\u00edaz","year":"2022","unstructured":"S\u00e1nchez-D\u00edaz M, Salvador-Rodr\u00edguez L, Cuenca-Barrales C, Arias-Santiago S, Molina-Leyva A. Exploring the role of systemic immune-inflammation index and neutrophil-lymphocyte ratio in cardiovascular risk stratification for patients with hidradenitis suppurativa: a cross-sectional study. J Dermatol. 2022;49(12):1238\u201344. https:\/\/doi.org\/10.1111\/1346-8138.16558.","journal-title":"J Dermatol"},{"issue":"2","key":"1733_CR74","doi-asserted-by":"publisher","DOI":"10.1111\/dth.14835","volume":"34","author":"T \u00c7etinarslan","year":"2021","unstructured":"\u00c7etinarslan T, T\u00fcrel Ermertcan A, \u00d6zyurt B, G\u00fcnd\u00fcz K. Evaluation of the laboratory parameters in hidradenitis suppurativa: can we use new inflammatory biomarkers? Dermatol Ther. 2021;34(2):e14835. https:\/\/doi.org\/10.1111\/dth.14835.","journal-title":"Dermatol Ther"},{"issue":"19","key":"1733_CR75","doi-asserted-by":"publisher","first-page":"9267","DOI":"10.26355\/eurrev_202310_33954","volume":"27","author":"Z Utlu","year":"2023","unstructured":"Utlu Z. Evaluation of systemic immune and inflammatory biomarkers in hidradenitis suppurativa. Eur Rev Med Pharmacol Sci. 2023;27(19):9267\u201372. https:\/\/doi.org\/10.26355\/eurrev_202310_33954.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"1733_CR76","first-page":"258","volume":"27","author":"A Chiricozzi","year":"2015","unstructured":"Chiricozzi A, Faleri S, Franceschini C, et al. AISI: a new disease severity assessment tool for hidradenitis suppurativa. Wounds. 2015;27(10):258\u201364.","journal-title":"Wounds"},{"issue":"5","key":"1733_CR77","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1159\/000531653","volume":"239","author":"M Yamanaka-Takaichi","year":"2023","unstructured":"Yamanaka-Takaichi M, Raffals LE, Ehman EC, Loftus EV Jr, Alavi A. Anemia and systemic inflammatory markers in patients with perianal disease: hidradenitis suppurativa and inflammatory bowel disease. Dermatology. 2023;239(5):843\u20138. https:\/\/doi.org\/10.1159\/000531653.","journal-title":"Dermatology"},{"issue":"2","key":"1733_CR78","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1001\/jamadermatol.2022.5710","volume":"159","author":"N Kearney","year":"2023","unstructured":"Kearney N, McCourt C, Hambly R, et al. Association of biologic treatment in hidradenitis suppurativa with reduced neutrophil-lymphocyte ratio and platelet-lymphocyte ratio. JAMA Dermatol. 2023;159(2):222\u20134. https:\/\/doi.org\/10.1001\/jamadermatol.2022.5710.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"1733_CR79","doi-asserted-by":"publisher","first-page":"208","DOI":"10.4103\/ijd.ijd_532_22","volume":"68","author":"Y Hayran","year":"2023","unstructured":"Hayran Y, \u015een O, Akta\u015f A. Systemic immune-inflammation index (SII) correlates with disease severity in hidradenitis suppurativa patients. Indian J Dermatol. 2023;68(2):208\u20139. https:\/\/doi.org\/10.4103\/ijd.ijd_532_22.","journal-title":"Indian J Dermatol"},{"issue":"4","key":"1733_CR80","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/15569527.2024.2387595","volume":"43","author":"K Kaya","year":"2024","unstructured":"Kaya K, Gevher \u00d6. Effect of adalimumab treatment on inflammatory and hematological parameters in patients with hidradenitis suppurativa. Cutan Ocul Toxicol. 2024;43(4):253\u20137. https:\/\/doi.org\/10.1080\/15569527.2024.2387595.","journal-title":"Cutan Ocul Toxicol"},{"issue":"11","key":"1733_CR81","first-page":"87","volume":"28","author":"NF Ya\u015far","year":"2016","unstructured":"Ya\u015far NF, Uylas MU, Baspinar M, et al. Evaluating the use of hematological parameters in staging hidradenitis suppurativa. Wounds. 2016;28(11):87\u201391.","journal-title":"Wounds"},{"key":"1733_CR82","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.12659\/msm.900212","volume":"23","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Ma W. Assessment of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in atopic dermatitis patients. Med Sci Monit. 2017;23:1340\u20136. https:\/\/doi.org\/10.12659\/msm.900212.","journal-title":"Med Sci Monit"},{"issue":"4","key":"1733_CR83","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1159\/000539365","volume":"240","author":"S Weissmann","year":"2024","unstructured":"Weissmann S, Babyev AS, Gordon M, Golan-Tripto I, Horev A. Hematological markers in children and adults with atopic dermatitis: a retrospective cohort study. Dermatology. 2024;240(4):597\u2013605. https:\/\/doi.org\/10.1159\/000539365.","journal-title":"Dermatology"},{"key":"1733_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2024.1461596","volume":"11","author":"Q Ding","year":"2024","unstructured":"Ding Q, Lin L, Li X, Xie X, Lu T. Association between systemic immune-inflammation index and atopic dermatitis: a cross-sectional study of NHANES 2001-2006. Front Med. 2024;11:1461596. https:\/\/doi.org\/10.3389\/fmed.2024.1461596.","journal-title":"Front Med"},{"issue":"10","key":"1733_CR85","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000041715","volume":"104","author":"S Basar Kilic","year":"2025","unstructured":"Basar Kilic S, Erdal H. Pan-immune inflammation value and systemic inflammatory index as a measure of systemic inflammation in patients with psoriasis: a retrospective study. Medicine (Baltimore). 2025;104(10):e41715. https:\/\/doi.org\/10.1097\/MD.0000000000041715.","journal-title":"Medicine (Baltimore)"},{"issue":"17","key":"1733_CR86","doi-asserted-by":"publisher","first-page":"5452","DOI":"10.3390\/jcm12175452","volume":"12","author":"H Albayrak","year":"2023","unstructured":"Albayrak H. Neutrophil-to-lymphocyte ratio, neutrophil-to-monocyte ratio, platelet-to-lymphocyte ratio, and systemic immune-inflammation index in psoriasis patients: response to treatment with biological drugs. J Clin Med. 2023;12(17):5452. https:\/\/doi.org\/10.3390\/jcm12175452.","journal-title":"J Clin Med"},{"issue":"4","key":"1733_CR87","doi-asserted-by":"publisher","first-page":"415","DOI":"10.17816\/dv678204","volume":"28","author":"NV Batkaeva","year":"2025","unstructured":"Batkaeva NV, Olisova OY. Role of integrated hematological biomarkers of systemic inflammation in assessing the effectiveness of anticytokine therapy in patients with psoriasis. Russ J Skin Venereol Dis. 2025;28(4):415\u201328. https:\/\/doi.org\/10.17816\/dv678204.","journal-title":"Russ J Skin Venereol Dis"},{"issue":"4","key":"1733_CR88","doi-asserted-by":"publisher","first-page":"536","DOI":"10.14744\/SEMB.2023.43569","volume":"57","author":"S Kulakli","year":"2023","unstructured":"Kulakli S, Oguz ID, Aksan B. Could blood cell-based inflammatory markers be used to monitor response to biologic therapy in psoriasis? Sisli Etfal Hastan Tip Bul. 2023;57(4):536\u201342. https:\/\/doi.org\/10.14744\/SEMB.2023.43569.","journal-title":"Sisli Etfal Hastan Tip Bul"},{"issue":"6","key":"1733_CR89","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s00403-024-02972-8","volume":"316","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Qian H, Kuang YH, Wang Y, Chen WQ, Zhu W. Evaluation of the inflammatory parameters as potential biomarkers of systemic inflammation extent and the disease severity in psoriasis patients. Arch Dermatol Res. 2024;316(6):229. https:\/\/doi.org\/10.1007\/s00403-024-02972-8.","journal-title":"Arch Dermatol Res"},{"issue":"1","key":"1733_CR90","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12865-021-00454-4","volume":"22","author":"WM Wang","year":"2021","unstructured":"Wang WM, Wu C, Gao YM, Li F, Yu XL, Jin HZ. Neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, and other hematological parameters in psoriasis patients. BMC Immunol. 2021;22(1):64. https:\/\/doi.org\/10.1186\/s12865-021-00454-4.","journal-title":"BMC Immunol"},{"issue":"3","key":"1733_CR91","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/1346-8138.13061","volume":"43","author":"DS Kim","year":"2016","unstructured":"Kim DS, Shin D, Lee MS, et al. Assessments of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in Korean patients with psoriasis vulgaris and psoriatic arthritis. J Dermatol. 2016;43(3):305\u201310. https:\/\/doi.org\/10.1111\/1346-8138.13061.","journal-title":"J Dermatol"},{"key":"1733_CR92","doi-asserted-by":"publisher","first-page":"97","DOI":"10.15570\/actaapa.2017.28","volume":"26","author":"M Polat","year":"2017","unstructured":"Polat M, Bugdayci G, Kaya H, O\u011fuzman H. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Turkish patients with chronic plaque psoriasis. Acta Dermatovenerol Alp Pannonica Adriat. 2017;26:97\u2013100. https:\/\/doi.org\/10.15570\/actaapa.2017.28.","journal-title":"Acta Dermatovenerol Alp Pannonica Adriat"},{"issue":"10","key":"1733_CR93","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1111\/1346-8138.13875","volume":"44","author":"A Asahina","year":"2017","unstructured":"Asahina A, Kubo N, Umezawa Y, et al. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and mean platelet volume in Japanese patients with psoriasis and psoriatic arthritis: response to therapy with biologics. J Dermatol. 2017;44(10):1112\u201321. https:\/\/doi.org\/10.1111\/1346-8138.13875.","journal-title":"J Dermatol"},{"issue":"7","key":"1733_CR94","doi-asserted-by":"publisher","first-page":"6111","DOI":"10.3390\/ijms24076111","volume":"24","author":"CSB Andersen","year":"2023","unstructured":"Andersen CSB, Kvist-Hansen A, Siewertsen M, et al. Blood cell biomarkers of inflammation and cytokine levels as predictors of response to biologics in patients with psoriasis. Int J Mol Sci. 2023;24(7):6111. https:\/\/doi.org\/10.3390\/ijms24076111.","journal-title":"Int J Mol Sci"},{"key":"1733_CR95","doi-asserted-by":"publisher","first-page":"1323174","DOI":"10.3389\/fimmu.2024.1323174","volume":"15","author":"R Ma","year":"2024","unstructured":"Ma R, Cui L, Cai J, et al. Association between systemic immune inflammation index, systemic inflammation response index and adult psoriasis: evidence from NHANES. Front Immunol. 2024;15:1323174. https:\/\/doi.org\/10.3389\/fimmu.2024.1323174.","journal-title":"Front Immunol"},{"key":"1733_CR96","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1305701","volume":"15","author":"X Zhao","year":"2024","unstructured":"Zhao X, Li J, Li X. Association between systemic immune-inflammation index and psoriasis: a population-based study. Front Immunol. 2024;15:1305701. https:\/\/doi.org\/10.3389\/fimmu.2024.1305701.","journal-title":"Front Immunol"},{"issue":"6","key":"1733_CR97","doi-asserted-by":"publisher","first-page":"601","DOI":"10.5021\/ad.2019.31.6.601","volume":"31","author":"E Akta\u015f Karabay","year":"2019","unstructured":"Akta\u015f Karabay E, Aksu \u00c7erman A, Demir D, K\u0131van\u00e7 Altunay I. The effects of systemic psoriasis therapies on the C-reactive protein and the neutrophil-lymphocyte ratio. Ann Dermatol. 2019;31(6):601\u201310. https:\/\/doi.org\/10.5021\/ad.2019.31.6.601.","journal-title":"Ann Dermatol"},{"issue":"6","key":"1733_CR98","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14101","volume":"75","author":"D Dincer Rota","year":"2021","unstructured":"Dincer Rota D, Tanacan E. The utility of systemic-immune inflammation index for predicting the disease activation in patients with psoriasis. Int J Clin Pract. 2021;75(6):e14101. https:\/\/doi.org\/10.1111\/ijcp.14101.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"1733_CR99","doi-asserted-by":"publisher","DOI":"10.4103\/ijd.ijd_935_21","volume":"67","author":"S Mondal","year":"2022","unstructured":"Mondal S, Guha S, Saha A, Ghoshal L, Bandyopadhyay D. Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic plaque psoriasis. Indian J Dermatol. 2022;67(4):477. https:\/\/doi.org\/10.4103\/ijd.ijd_935_21.","journal-title":"Indian J Dermatol"},{"issue":"4","key":"1733_CR100","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13457","volume":"33","author":"N Najar Nobari","year":"2020","unstructured":"Najar Nobari N, Shahidi Dadras M, Nasiri S, Abdollahimajd F, Gheisari M. Neutrophil\/platelet to lymphocyte ratio in monitoring of response to TNF-\u03b1 inhibitors in psoriatic patients. Dermatol Ther. 2020;33(4):e13457. https:\/\/doi.org\/10.1111\/dth.13457.","journal-title":"Dermatol Ther"},{"issue":"2","key":"1733_CR101","doi-asserted-by":"publisher","first-page":"202","DOI":"10.5114\/ada.2020.94838","volume":"37","author":"I An","year":"2020","unstructured":"An I, Ucmak D, Ozturk M. The effect of biological agent treatment on neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, mean platelet volume, and C-reactive protein in psoriasis patients. Adv Dermatol Allergol. 2020;37(2):202\u20136. https:\/\/doi.org\/10.5114\/ada.2020.94838.","journal-title":"Adv Dermatol Allergol"},{"issue":"8","key":"1733_CR102","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12083046","volume":"12","author":"E Sugimoto","year":"2023","unstructured":"Sugimoto E, Matsuda H, Shibata S, et al. Impact of pretreatment systemic inflammatory markers on treatment persistence with biologics and conventional systemic therapy: a retrospective study of patients with Psoriasis vulgaris and psoriatic arthritis. J Clin Med. 2023;12(8):3046. https:\/\/doi.org\/10.3390\/jcm12083046.","journal-title":"J Clin Med"},{"issue":"8","key":"1733_CR103","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43790","volume":"15","author":"G \u015eener","year":"2023","unstructured":"\u015eener G, \u0130nan Yuksel E, G\u00f6kdeniz O, et al. The relationship of hematological parameters and C-reactive protein (CRP) with disease presence, severity, and response to systemic therapy in patients with psoriasis. Cureus. 2023;15(8):e43790. https:\/\/doi.org\/10.7759\/cureus.43790.","journal-title":"Cureus"},{"issue":"6","key":"1733_CR104","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1272\/jnms.JNMS.2022_89-613","volume":"89","author":"S Annen","year":"2022","unstructured":"Annen S, Horiguchi G, Teramukai S, et al. Association of transition of laboratory markers with transition of disease activity in psoriasis patients treated with biologics. J Nippon Med Sch. 2022;89(6):587\u201393. https:\/\/doi.org\/10.1272\/jnms.JNMS.2022_89-613.","journal-title":"J Nippon Med Sch"},{"issue":"8","key":"1733_CR105","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037236","volume":"103","author":"HH Guo","year":"2024","unstructured":"Guo HH, Chen RX. Association of systemic inflammation index with psoriasis risk and psoriasis severity: a retrospective cohort study of NHANES 2009 to 2014. Medicine (Baltimore). 2024;103(8):e37236. https:\/\/doi.org\/10.1097\/MD.0000000000037236.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"1733_CR106","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077596","volume":"13","author":"J Hong","year":"2023","unstructured":"Hong J, Lian N, Li M. Association between the neutrophil-to-lymphocyte ratio and psoriasis: a cross-sectional study of the National Health and Nutrition Examination Survey 2011-2014. BMJ Open. 2023;13(12):e077596. https:\/\/doi.org\/10.1136\/bmjopen-2023-077596.","journal-title":"BMJ Open"},{"issue":"1","key":"1733_CR107","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1080\/15569527.2023.2275020","volume":"43","author":"M Esen","year":"2024","unstructured":"Esen M. The effect of IL17 and IL23 inhibitors on hematological parameters and C-reactive protein in psoriasis patients. Cutan Ocul Toxicol. 2024;43(1):38\u201345. https:\/\/doi.org\/10.1080\/15569527.2023.2275020.","journal-title":"Cutan Ocul Toxicol"},{"issue":"2","key":"1733_CR108","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00109-023-02406-4","volume":"102","author":"KS Kommoss","year":"2024","unstructured":"Kommoss KS, Bieler T, Ringen J, et al. A simple tool for evaluation of inflammation in psoriasis: neutrophil-to-lymphocyte and platelet-to-lymphocyte ratio as markers in psoriasis patients and related murine models of psoriasis-like skin disease. J Mol Med (Berl). 2024;102(2):247\u201355. https:\/\/doi.org\/10.1007\/s00109-023-02406-4.","journal-title":"J Mol Med (Berl)"},{"key":"1733_CR109","doi-asserted-by":"publisher","first-page":"387","DOI":"10.21276\/apalm.2546","volume":"6","author":"SK Yadav","year":"2019","unstructured":"Yadav SK, Sharma S, Singh S, Khurana VK, Sarin N. Neutrophil to lymphocyte ratio and platelet lymphocyte ratio: novel markers of inflammation in psoriasis. Ann Pathol Lab Med. 2019;6:387\u201391. https:\/\/doi.org\/10.21276\/apalm.2546.","journal-title":"Ann Pathol Lab Med"},{"key":"1733_CR110","doi-asserted-by":"publisher","DOI":"10.4081\/dr.2022.9516","author":"HT Nguyen","year":"2022","unstructured":"Nguyen HT, Vo LDH, Pham NN. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as inflammatory markers in psoriasis: a case-control study. Dermatol Rep. 2022. https:\/\/doi.org\/10.4081\/dr.2022.9516.","journal-title":"Dermatol Rep."},{"issue":"6","key":"1733_CR111","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14114","volume":"75","author":"\u0130 An","year":"2021","unstructured":"An \u0130, Aksoy M, Ayhan E, Ozturk M. The effect of Secukinumab treatment on inflammatory parameters in patients with psoriasis: a multicentre retrospective study. Int J Clin Pract. 2021;75(6):e14114. https:\/\/doi.org\/10.1111\/ijcp.14114.","journal-title":"Int J Clin Pract"},{"issue":"5","key":"1733_CR112","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1016\/j.abd.2020.02.008","volume":"95","author":"MC Sirin","year":"2020","unstructured":"Sirin MC, Korkmaz S, Erturan I, et al. Evaluation of monocyte to HDL cholesterol ratio and other inflammatory markers in patients with psoriasis. An Bras Dermatol. 2020;95(5):575\u201382. https:\/\/doi.org\/10.1016\/j.abd.2020.02.008.","journal-title":"An Bras Dermatol"},{"issue":"4","key":"1733_CR113","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1007\/s11845-025-03969-6","volume":"194","author":"MS \u00c7elik","year":"2025","unstructured":"\u00c7elik MS, Akta\u015f H. The effect of IL-17 and IL-23 \u0131nhibitors on hematological \u0131nflammatory parameters in patients with psoriasis vulgaris. Ir J Med Sci. 2025;194(4):1329\u201334. https:\/\/doi.org\/10.1007\/s11845-025-03969-6.","journal-title":"Ir J Med Sci"},{"issue":"1","key":"1733_CR114","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02304-0","volume":"30","author":"X Yang","year":"2025","unstructured":"Yang X, Pan Y, Zhang Y, et al. Association of systemic immune-inflammation index (SII) with risk of psoriasis: a cross-sectional analysis of National Health and Nutrition Examination Survey 2011-2014. Eur J Med Res. 2025;30(1):58. https:\/\/doi.org\/10.1186\/s40001-025-02304-0.","journal-title":"Eur J Med Res"},{"key":"1733_CR115","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4274\/haseki.galenos.2023.9050","volume":"61","author":"S Kulakli","year":"2023","unstructured":"Kulakli S, Oguz ID. Effect of biological therapy on systemic inflammatory markers among patients with chronic plaque psoriasis. Haseki Tip Bul. 2023;61:154\u201360. https:\/\/doi.org\/10.4274\/haseki.galenos.2023.9050.","journal-title":"Haseki Tip Bul"},{"issue":"1","key":"1733_CR116","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-024-03768-6","volume":"317","author":"N Demirel \u00d6\u011f\u00fct","year":"2025","unstructured":"Demirel \u00d6\u011f\u00fct N, Ayano\u011flu MA, Ko\u00e7 Y\u0131ld\u0131r\u0131m S, et al. Are IL-17 inhibitors superior to IL-23 inhibitors in reducing systemic inflammation in moderate-to-severe plaque psoriasis? A retrospective cohort study. Arch Dermatol Res. 2025;317(1):232. https:\/\/doi.org\/10.1007\/s00403-024-03768-6.","journal-title":"Arch Dermatol Res"},{"issue":"12","key":"1733_CR117","doi-asserted-by":"publisher","first-page":"e1032","DOI":"10.1111\/jdv.20813","volume":"39","author":"E Berna-Rico","year":"2025","unstructured":"Berna-Rico E, P\u00e9rez-Garc\u00eda B, Abbad-Jaime de Arag\u00f3n C, et al. Subclinical atherosclerosis is increased in moderate-to-severe atopic dermatitis. J Eur Acad Dermatol Venereol. 2025;39(12):e1032\u20135. https:\/\/doi.org\/10.1111\/jdv.20813.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"19","key":"1733_CR118","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910402","volume":"22","author":"K Wierzbowska-Drabik","year":"2021","unstructured":"Wierzbowska-Drabik K, Lesiak A, Skibi\u0144ska M, et al. Psoriasis and atherosclerosis-skin, joints, and cardiovascular story of two plaques in relation to the treatment with biologics. Int J Mol Sci. 2021;22(19):10402. https:\/\/doi.org\/10.3390\/ijms221910402.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1733_CR119","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.jaad.2016.03.025","volume":"75","author":"MA Gonz\u00e1lez-L\u00f3pez","year":"2016","unstructured":"Gonz\u00e1lez-L\u00f3pez MA, Hern\u00e1ndez JL, Lacalle M, et al. Increased prevalence of subclinical atherosclerosis in patients with hidradenitis suppurativa (HS). J Am Acad Dermatol. 2016;75(2):329\u201335. https:\/\/doi.org\/10.1016\/j.jaad.2016.03.025.","journal-title":"J Am Acad Dermatol"},{"issue":"6917","key":"1733_CR120","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/nature01323","volume":"420","author":"P Libby","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002;420(6917):868\u201374. https:\/\/doi.org\/10.1038\/nature01323.","journal-title":"Nature"},{"issue":"8","key":"1733_CR121","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.89794","volume":"17","author":"FH Shah","year":"2025","unstructured":"Shah FH, Agrawal S, Tated RC, Maheta D, Naqvi S. Novel biomarkers and advanced imaging in cardiovascular risk stratification for rheumatic diseases. Cureus. 2025;17(8):e89794. https:\/\/doi.org\/10.7759\/cureus.89794.","journal-title":"Cureus"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01733-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01733-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01733-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T03:23:43Z","timestamp":1781753023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01733-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":121,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1733"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01733-x","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"26 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Julia Alicja Lewandowska and Agnieszka Owczarczyk\u2013Saczonek have nothing to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}